Difference between revisions of "Mitochondria-Targeted Drug Development 2021 Virtual"

Latest revision as of 17:29, 9 February 2021

MitoGlobal first

Mitochondria-Targeted Drug Development 2021 Virtual

Virtual , 2021 Apr 27-29. Mitochondria-Targeted Drug Development Summit

» https://mitochondria-targets.com/

hansonwade (2021-04-27) MitoGlobal

Abstract: Mitochondria-Targeted Drug Development Summit, Digital, 2021.

General information

The Digital Mitochondria-Targeted Drug Development Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what’s next to help you accelerate your pipeline into the clinic.

Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial & Age-related Diseases.

Download the brochure here

Program

The program is available here

Registration

Register here

Early bird & Team Discounts Available

Organizer

Hanson Wade

Mail: [email protected]

https://hansonwade.com/

Speaker

Our 25+ expert speakers include:

Douglas Wallace, Pediatric Mitochondrial Medicine & Metabolic Disease, Center for Mitochondrial & Epigenomic Medicine & University of Pennsylvania
Magali Taiel, GenSight Biologics
Mike Murphy, University of Cambridge
Steven Engle, CohBar Inc
John Geisler, Mitochon Pharmaceuticals
Paul Thompson, MISSION Therapeutics
Reenie McCarthy, Stealth BioTherapeutics

See the full list of speakers here

Listed under MitoGlobal Events.

Labels:

2021, MitoGlobal

@@ Line 1: / Line 1: @@
 {{MitoGlobal header page name}}
 {{Publication
-|title='''Virtual ''', 2021 Apr 27-29. Mitochondria-Targeted Drug Development Summit
+|title=[[File:21640 - Mitochondria Targeted Therapeutics logo NEW.jpg|right|200px|Mitochondria Targeted Therapeutics]]'''Virtual ''', 2021 Apr 27-29. Mitochondria-Targeted Drug Development Summit
 |info=https://mitochondria-targets.com/
 |authors=hansonwade
@@ Line 13: / Line 13: @@
 == General information ==
+:::: The '''Digital Mitochondria-Targeted Drug Development Summit''' is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what’s next to help you accelerate your pipeline into the clinic.
+:::: Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial & Age-related Diseases.
 :::: Download the brochure [https://wiki.oroboros.at/images/1/16/Mitochondria-Targeted_Drug_Development_2021_Brochure.pdf here]
@@ Line 20: / Line 24: @@
 == Registration ==
 :::: Register [https://mitochondria-targets.com/take-part/register/ here]
-:::: Deadline Early bird: 2021-02-12
+:::: Early bird & Team Discounts Available
 == Organizer ==
-:::: Hansonwade
+:::: Hanson Wade
+:::: Mail: [mailto:[email protected] [email protected]]
 :::: [https://hansonwade.com/ https://hansonwade.com/]
 == Speaker ==
-:::: List of speakers available [https://mitochondria-targets.com/program/speakers/ here]
+:::: Our 25+ expert speakers include:
+::::* [[Wallace DC|Douglas Wallace]], Pediatric Mitochondrial Medicine & Metabolic Disease, Center for Mitochondrial & Epigenomic Medicine & University of Pennsylvania
+::::* Magali Taiel, GenSight Biologics
+::::* [[Murphy Michael P|Mike Murphy]], University of Cambridge
+::::* Steven Engle, CohBar Inc
+::::* John Geisler, Mitochon Pharmaceuticals
+::::* Paul Thompson, MISSION Therapeutics
+::::* Reenie McCarthy, Stealth BioTherapeutics
+:::: See the full list of speakers [https://mitochondria-targets.com/program/speakers/ here]